Arovella Therapeutics LtdHere is the public summary page for Arovella Therapeutics Ltd. Please login to see the complete information for Arovella Therapeutics Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Arovella Therapeutics Ltd stacks up relative to its peers. |
| Darwin Score | +22 |
| Ticker | ALA |
| Latest Price | 0.11 AUD as of close on 16-Jul-2025 |
| 3 Month price range | 0.07 to 0.11 AUD |
| Market Capitalisation | 124.80Mn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally. The company product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia. See More ... |
| Company URL | https://www.arovella.com |
| See Darwins Full Analysis for Arovella Therapeutics Ltd |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Arovella Therapeutics Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +17 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +6 |
Alerts
There are 3 live alerts for Arovella Therapeutics Ltd.
- Price is at a 5d high. (Positive)
- Overbought - The 5 week RSI is +79.4. (Negative)
- 5d RSI Overbought. This alert has occurred 55 times over the last last year. The average forward returns are -4.7% over 5 days, -7.5% over 10 days, -12.1% over 15 days and -14.5% over 20 days. (Positive)
Peer Comparison
There are 12 peers of Arovella Therapeutics Ltd.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | +6 |
| CSL Ltd (CSL) | Biotechnology | +19 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | +4 |
| Imugene Ltd (IMU) | Biotechnology | -31 |
| Mesoblast Ltd (MSB) | Biotechnology | +12 |
| Opthea Ltd (OPT) | Biotechnology | -10 |
| PYC Therapeutics Ltd (PYC) | Biotechnology | +22 |
| Paradigm Biopharmaceuticals Ltd (PAR) | Biotechnology | +4 |
| Polynovo Ltd (PNV) | Biotechnology | +4 |
| Race Oncology Ltd (RAC) | Biotechnology | -20 |
| Telix Pharmaceuticals Ltd (TLX) | Biotechnology | +10 |
| Tissue Repair Ltd (TRP) | Biotechnology | +7 |
Share 
